These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22188725)

  • 1. Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
    Napoleone E; Cutrone A; Cugino D; Amore C; Di Santo A; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
    Thromb Res; 2012 Jun; 129(6):736-42. PubMed ID: 22188725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
    Chen X; Meng Q; Zhao Y; Liu M; Li D; Yang Y; Sun L; Sui G; Cai L; Dong X
    Cancer Lett; 2013 Jan; 328(2):318-24. PubMed ID: 23092556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo.
    Bluff JE; Amarzguioui M; Slattery J; Reed MW; Brown NJ; Staton CA
    Breast Cancer Res Treat; 2011 Aug; 128(3):691-701. PubMed ID: 20830515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aliskiren, a renin inhibitor, downregulates TNF-α-induced tissue factor expression in HUVECS.
    Del Fiorentino A; Cianchetti S; Celi A; Pedrinelli R
    J Renin Angiotensin Aldosterone Syst; 2010 Dec; 11(4):243-7. PubMed ID: 20798130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells.
    Napoleone E; Cutrone A; Cugino D; Latella MC; Zurlo F; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
    Thromb Res; 2012 May; 129(5):641-7. PubMed ID: 21840575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
    He M; He X; Xie Q; Chen F; He S
    Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose potentiates and renin-angiotensin blockade downregulates LPS-induced tissue factor expression in human mononuclear cells.
    Balia C; Petrini S; Cordazzo C; Cianchetti S; Neri T; Celi A; Pedrinelli R
    Thromb Res; 2012 Sep; 130(3):552-6. PubMed ID: 22817879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells.
    Napoleone E; Zurlo F; Latella MC; Amore C; Di Santo A; Iacoviello L; Donati MB; Lorenzet R
    Eur J Cancer; 2009 Feb; 45(3):470-7. PubMed ID: 19046877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart.
    Siddiqui AJ; Mansson-Broberg A; Gustafsson T; Grinnemo KH; Dellgren G; Hao X; Fischer H; Sylvén C
    Am J Hypertens; 2005 Oct; 18(10):1347-52. PubMed ID: 16202860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human breast stromal cells on conjugated linoleic acid (CLA) modulated vascular endothelial growth factor-A (VEGF-A) expression in MCF-7 cells.
    Wang LS; Huang YW; Sugimoto Y; Liu S; Chang HL; Ye W; Shu S; Lin YC
    Anticancer Res; 2005; 25(6B):4061-8. PubMed ID: 16312046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes.
    Napoleone E; Di Santo A; Camera M; Tremoli E; Lorenzet R
    Circ Res; 2000 Feb; 86(2):139-43. PubMed ID: 10666408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system in the breast and breast cancer.
    Vinson GP; Barker S; Puddefoot JR
    Endocr Relat Cancer; 2012 Feb; 19(1):R1-19. PubMed ID: 22180497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Tsujinoue H; Imazu H; Fukui H
    Int J Oncol; 2002 Jun; 20(6):1227-31. PubMed ID: 12012003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer.
    Herr D; Rodewald M; Fraser HM; Hack G; Konrad R; Kreienberg R; Wulff C
    Gynecol Oncol; 2008 Jun; 109(3):418-25. PubMed ID: 18395779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.
    Araújo WF; Naves MA; Ravanini JN; Schor N; Teixeira VP
    Urol Oncol; 2015 Sep; 33(9):389.e1-7. PubMed ID: 25595575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.